tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Agios Pharmaceuticals (AGIO)
NASDAQ:AGIO
US Market
AGIO
Agios Pharma
RESEARCH TOOLSreports

Agios Pharma (AGIO) Stock News & Sentiment

Compare
676 Followers
Agios Expands Rare-Disease Pipeline With New Phase 1b PKU Study of AG-181
Premium
Company Announcements
Agios Expands Rare-Disease Pipeline With New Phase 1b PKU Study of AG-181
7d ago
AGIO
Vorasidenib’s Real-World Test in Germany: What Agios Investors Should Watch
Premium
Company Announcements
Vorasidenib’s Real-World Test in Germany: What Agios Investors Should Watch
22d ago
AGIO
Agios Pharma Sets 2026 Strategic Priorities After AQVESME Approval
Premium
Company Announcements
Agios Pharma Sets 2026 Strategic Priorities After AQVESME Approval
25d ago
8K
AGIO
Agios Pharma: Broad Aqvesme Label, Premium Pricing, and Manageable Safety Profile Support Buy Rating and 54.5% Upside Potential
Premium
Ratings
Agios Pharma: Broad Aqvesme Label, Premium Pricing, and Manageable Safety Profile Support Buy Rating and 54.5% Upside Potential
1M ago
AGIO
Agios Pharmaceuticals: Thalassemia Approval, Premium Pricing, and Manageable REMS Drive Higher Target and Undervalued Buy Thesis
Premium
Ratings
Agios Pharmaceuticals: Thalassemia Approval, Premium Pricing, and Manageable REMS Drive Higher Target and Undervalued Buy Thesis
1M ago
AGIO
Agios: FDA Approval of Aqvesme in Thalassemia Unlocks Transformational Market Opportunity, Supporting Buy Rating and Higher Target
Premium
Ratings
Agios: FDA Approval of Aqvesme in Thalassemia Unlocks Transformational Market Opportunity, Supporting Buy Rating and Higher Target
1M ago
AGIO
Here’s Why Agios Stock (AGIO) Is Suddenly on the Rise Today
Premium
Market News
Here’s Why Agios Stock (AGIO) Is Suddenly on the Rise Today
1M ago
AGIO
More AGIO News >

AGIO News on the Web

Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks
Bullish
Williams to Report Q4 Earnings: What Surprise Awaits Investors?
Zacks
Bullish
Agios Expands Rare-Disease Pipeline With New Phase 1b PKU Study of AG-181
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Agios Pharma (AGIO) and Henry Schein (HSIC)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: HeartBeam (BEAT) and Agios Pharma (AGIO)
TipRanks News
Bullish
Vorasidenib’s Real-World Test in Germany: What Agios Investors Should Watch
TipRanks News
Bullish
Analysts’ Top Healthcare Picks: Wave Life Sciences (WVE), Guardian Pharmacy Services, Inc. Class A (GRDN)
TipRanks News
Bullish
Analysts’ Top Healthcare Picks: Crinetics Pharmaceuticals (CRNX), Denali Therapeutics (DNLI)
TipRanks News
Bullish

News Score - Last 7 Days

Positive
AGIO
Sector Average
Media Buzz
This Week2 articles
Weekly Average3 articles
News Sentiment
This Week100%
Sector Average74%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AGIO’s Media Buzz Sentiment?
2 articles about AGIO were published this week. In an average week, 3 articles are published.
    What is AGIO’s weekly average amount of articles?
    In an average week, 3 articles about AGIO are published.
      What is AGIO’s News Sentiment?
      100% of articles about AGIO were positive this week, compared to its sector average of 74%.
        Healthcare Stocks that are Trending in the News
        MMSIMerit Medical Systems
        TECHBio-Techne
        EHCEncompass Health
        ROIVRoivant Sciences
        DVADaVita
        Showing the stocks with the most bullish news sentiment over the past week